SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G - Statement of Beneficial Ownership by Certain Investors:
SEC Accession No. 0000728889-18-000215
Filing Date
2018-02-06
Accepted
2018-02-06 13:01:21
Documents
1

Document Format Files

Seq Description Document Type Size
1 FORM 13G arrowheadpharmace.htm SC 13G 24572
  Complete submission text file 0000728889-18-000215.txt   26615
Mailing Address 225 LIBERTY STREET NEW YORK NY 10281-1008
Business Address 225 LIBERTY STREET NEW YORK NY 10281-1008 212-323-0200
OppenheimerFunds, Inc. (Filed by) CIK: 0000728889 (see all company filings)

IRS No.: 000000000 | State of Incorp.: CO | Fiscal Year End: 1231
Type: SC 13G
SIC: 0000

Mailing Address 225 SOUTH LAKE AVENUE SUITE 1050 PASADENA CA 91101
Business Address 225 SOUTH LAKE AVENUE SUITE 1050 PASADENA CA 91101 626-304-3400
ARROWHEAD PHARMACEUTICALS, INC. (Subject) CIK: 0000879407 (see all company filings)

IRS No.: 460408024 | State of Incorp.: DE | Fiscal Year End: 0930
Type: SC 13G | Act: 34 | File No.: 005-48710 | Film No.: 18576948
SIC: 2834 Pharmaceutical Preparations